Prevalence of β-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark

Microbial Drug Resistance

Volumn 10, Issue 4, 2004, Pages 334-340

  Olesen, Inger ^a   Hasman, Henrik ^a   Aarestrup, Frank Møller ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ASPARAGINE; ASPARTIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE AMPC; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTIOFUR; GLUTAMIC ACID; HISTIDINE;

AMINO ACID SUBSTITUTION; ANIMAL DISEASE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BLA OXA GENE; BLA PSE GENE; BLA TEM 1 GENE; BLA TEM 127 GENE; BLA TEM 128 GENE; BLA TEM 1A GENE; BLA TEM 1B GENE; BLA TEM 1C GENE; BLA TEM 30 GENE; CATTLE; CONTROLLED STUDY; DENMARK; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; POULTRY; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA; SWINE;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; ESCHERICHIA COLI; PROKARYOTA; SALMONELLA; SUS SCROFA;

EID: 11844299639     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2004.10.334     Document Type: Article

References (24)

1. Ambler, R.P., A.F. Coulson, J.M. Frere, J.M. Ghuysen, B. Joris, M. Forsman, R.C. Levesque, G. Tiraby, and S.G. Waley. 1991. A standard numbering scheme for the class A beta-lactamases. Biochem. J. 276:269-270.
2. Belaaouaj, A., C. Lapoumeroulie, M.M. Canica, G. Vedel, P. Nevot, R. Krishnamoorthy, and G. Paul. 1994. Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol. Lett. 120:75-80.
3. Brinas, L., M.A. Moreno, T. Teshager, M. Zarazaga, Y. Saenz, C. Porrero, L. Dominguez, and C. Torres. 2003. Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain. Microb. Drug Resist. 9:201-209.
4. Brinas, L., M. Zarazaga, Y. Saenz, F. Ruiz-Larrea, and C. Torres. 2002. Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob. Agents Chemother. 46:3156-3163.
5. Caroff, N., E. Espaze, D. Gautreau, H. Richet, and A. Reynaud. 2000. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. J. Antimicrob. Chemother. 45:783-788.
6. Corvec, S., N. Caroff, E. Espaze, J. Marraillac, and A. Reynaud. 2002. -11 Mutation in the ampC promoter increasing resistance to beta-lactams in a clinical Escherichia coli strain. Antimicrob. Agents Chemother. 46:3265-3267.
7. DANMAP. 2003. DANMAP 2002-Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Danish Institute for Food and Veterinary Research, Copenhagen, Denmark.
8. Goussard, S., and P. Courvalin. 1991. Sequence of the genes blaT-1B and blaT-2. Gene 102:71-73.
9. Hansen, L.H., S.J. Sorensen, and L.B. Jensen. 1997. Chromosomal insertion of the entire Escherichia coli lactose operon, into two strains of Pseudomonas, using a modified mini-Tn5 delivery system. Gene 186:167-173.
10. Hasman, H., M.A. Schembri, and P. Klemm. 2000. Antigen 43 and type 1 fimbriae determine colony morphology of Escherichia coli K-12. J. Bacteriol. 182:1089-1095.
11. Jaurin, B., T. Grundstrom, T. Edlund, and S. Normark. 1981. The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation. Nature 290:221-225.
12. Lartigue, M.F., V. Leflon-Guibout, L. Poirel, P. Nordmann, and M.H. Nicolas-Chanoine. 2002. Promoters P3, Pa/Pb, P4, and P5 upstream from bla(TEM) genes and their relationship to beta-lactam resistance. Antimicrob. Agents Chemother. 46:4035-4037.
13. Livermore, D.M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
14. Medeiros, A.A., T.F. O'Brien, E.Y. Rosenberg, and H. Nikaido. 1987. Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy. J. Infect. Dis. 156:751-757.
15. National Comittee for Clinical Laboratory Standards. 2003. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically; Approved Standard, 6th ed. M7-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
16. Nelson, E.C., and B.G. Elisha. 1999. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 43:957-959.
17. Okusu, H., D. Ma, and H. Nikaido. 1996. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J. Bacteriol. 178:306-308.
18. Olsson, O., S. Bergstrom, and S. Normark. 1982. Identification of a novel ampC β-lactamase promoter in a clinical isolate of Escherichia coli. EMBO J. 1:1411-1416.
19. Rice, R.B., and R.A. Bonomo. 1996. Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents. In V. Lorian (ed.), Antibiotics in laboratory medicine. 4th ed. Williams & Wilkins, Baltimore, Philadelphia, London, Paris, Bangkok, Buenos Aires, Hong Kong, Munich, Sydney, Tokyo, Wroclaw, pp. 453-501.
20. Sawai, T., A. Yamaguchi, and R. Hiruma. 1988. Effect of interaction between outer membrane permeability and β-lactamase production on resistance to β-lactam agents in gram-negative bacteria. Rev. Infect. Dis. 10:761-764.
21. Shannon, K., H. Williams, A. King, and I. Phillips. 1990. Hyperproduction of TEM-1 β-lactamase in clinical isolates of Escherichia coli serotype O15. FEMS Microbiol. Lett. 55:319-323.
22. Sirot, D. 1995. Extended-spectrum plasmid-mediated β-lactamases. J. Antimicrob. Chemother. 36(Suppl A):19-34.
23. Vedel, G., A. Belaaouaj, L. Gilly, R. Labia, A. Philippon, P. Nevot, and G. Paul. 1992. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors. J. Antimicrob. Chemother. 30:449-462.
24. Wang, X., G. Minasov, and B.K. Shoichet. 2002. Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J. Mol. Biol. 320:85-95.